The cyber incident creates headline risk and potential liability from patient PHI exposure, even if core operations are unaffected. The proximate CISO/CTO departure suggests internal accountability actions, which may signal deeper security weaknesses. Monitor for class-action lawsuits, regulatory fines (HIPAA), and potential customer churn. The stock could face near-term pressure from reputational damage and uncertainty around the scope of exfiltrated data.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 16 $108.84entry
- T+1 · 5mo ago −6.48%α −5.23% · $101.79
- T+5 · 5mo ago +1.18%α +3.41% · $110.12
- T+20 · 4mo ago +3.41%α +3.21% · $112.55
- T+60 · 2mo ago +3.71%α +2.71% · $112.88
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
iRhythm disclosed a material cybersecurity incident in an 8-K filed June 15, 2026. A threat actor exfiltrated proprietary data and patient protected health information from third-party-hosted business applications via social engineering and is demanding payment. The company states it has not impacted clinical systems, patient safety, or financial reporting, and believes the incident is not reasonably likely to have a material financial impact. However, the disclosure comes just 18 days after a CISO/CTO departure, heightening governance concerns.
Key Facts
- On June 8, 2026, iRhythm identified unauthorized activity on third-party-hosted business applications.
- On June 9, a threat actor claimed to have obtained proprietary data and patient PHI; data exfiltration was confirmed.
- The company determined the incident is material on June 10, 2026, based on the volume of potentially affected data.
- The incident was caused by social engineering; clinical/medical device systems and financial reporting systems were not impacted.
- The company maintains cybersecurity insurance but cannot assure coverage will be sufficient.
- A prior 8-K on May 28, 2026 reported an executive departure (CISO/CTO likely), occurring 18 days before this cyber incident disclosure.
- No ongoing unauthorized access has been identified as of the filing date.
Financial Impact
The company believes the incident is not reasonably likely to have a material impact on financial condition or results of operations. No specific dollar amounts disclosed.
Risk Factors
- Potential class-action litigation from affected patients over PHI exposure.
- Regulatory penalties from HIPAA or state privacy regulators.
- Reputational damage with healthcare provider customers, leading to contract losses.
- Ransom payment or remediation costs exceeding insurance coverage.
- Further disclosure of material details in amended 8-K could reveal broader impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001388658-26-000055 |
| Document: 0001388658-26-000055-index-headers.html | 0001388658-26-000055 |
| Document: 0001388658-26-000055-index.html | 0001388658-26-000055 |
| Document: 0001388658-26-000055.txt | 0001388658-26-000055 |
Track record
31 reports on IRTC
8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
- Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 11, 20265d ago Press Release Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 5, 202611d ago 8-K Mixed 6/10 No price data
- Nov 5, 202611d ago Press Release Bullish 6/10 Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
- Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers